Myron Kaplan - May 17, 2021 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role
Director
Signature
/s/ Myron Kaplan
Stock symbol
CRMD
Transactions as of
May 17, 2021
Transactions value $
$90,477
Form type
4
Date filed
5/19/2021, 05:40 PM
Next filing
Nov 19, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRMD Common Stock Purchase $90.5K +15K +10% $6.03 165K May 17, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CRMD Stock Option (Right to Buy Common Stock) 30K May 17, 2021 Common Stock 30K $8.32 Direct F2
holding CRMD Stock Option (Right to Buy Common Stock) 15K May 17, 2021 Common Stock 15K $5.63 Direct F3
holding CRMD Stock Option (Right to Buy Common Stock) 15K May 17, 2021 Common Stock 15K $8.30 Direct F4
holding CRMD Stock Option (Right to Buy Common Stock) 8K May 17, 2021 Common Stock 8K $2.85 Direct F5
holding CRMD Stock Option (Right to Buy Common Stock) 8K May 17, 2021 Common Stock 8K $11.20 Direct F6
holding CRMD Stock Option (Right to Buy Common Stock) 10K May 17, 2021 Common Stock 10K $21.40 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $5.98 to $6.09. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F2 These options were granted on 1/11/2021. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.
F3 These options were granted on 02/25/2020. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.
F4 These options were granted on 01/10/2019. These options are fully vested.
F5 These options were granted on 02/16/2018. These options are fully vested.
F6 These options were granted on 02/21/2017. These options are fully vested.
F7 These options were granted on 4/28/2016. These options are fully vested.

Remarks:

The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split.